store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Apelin-13 是存在于中枢和外周神经系统由13个氨基酸组成的多肽序列,是 G 蛋白偶联受体angiotensin II protein J (APJ) 的内源性配体,对 APJ 的 EC50 值为 0.37 nM。Apelin-13 具有扩张血管和降压活性,可用于研究 2 型糖尿病综合征。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 478 | 现货 | ||
5 mg | ¥ 683 | 现货 | ||
10 mg | ¥ 1,025 | 现货 | ||
25 mg | ¥ 2,105 | 现货 | ||
50 mg | ¥ 3,158 | 现货 | ||
100 mg | ¥ 4,736 | 现货 | ||
200 mg | ¥ 7,104 | 现货 | ||
500 mg | ¥ 10,657 | 现货 |
产品描述 | Apelin-13 is a 13-amino acid peptide sequence found in the central and peripheral nervous system that is an endogenous ligand for the G protein-coupled receptor angiotensin II protein J (APJ), with an EC50 value of 0.37 nM for APJ.Apelin-13 has vasodilatory and antihypertensive activity and can be used to study type 2 diabetic syndrome. Apelin-13 has vasodilatory and antihypertensive activities and can be used to study type 2 diabetes syndrome. |
靶点活性 | APJ:0.37 nM |
体外活性 | In cultured PC12 cells, the same protective effects were also observed.?Silencing Nrf2 gene with its siRNA abolished the Apelin 13's prevention of I/R-induced PC12 cell injury, oxidative stress, and inflammation.?Inhibition of AMPK by its siRNA decreased the level of Apelin 13-induced Nrf2 expression and diminished the protective effects of Apelin 13.?The interplay relationship between GSK-3β and Nrf2 was also verified with relative overexpression.?Using selective inhibitors, we further identified the upstream of AMPK/GSK-3β/Nrf2 is AR/Gα/PLC/IP3/CaMKK. |
体内活性 |
Administered intraperitoneally at a daily dosage of 200 µg/kg for 4 weeks, Apelin-13 improves cardiac function, insulin resistance, and lipid metabolism. It significantly decreases serum levels of TNF-α and leptin, induces the expression of Apelin-12 in serum, and markedly elevates levels of GLUT4 and p-AMPKα2[2]. When delivered via intracerebroventricular injection at single dosages of 10 and 100 μM, Apelin-13 increases the spontaneous discharges in the majority of pallidal neurons[3]. |
细胞实验 | For in vitro study, PC12 cells were used,proteases inhibitors or siRNA were used.?Protein levels were investigated by western blotting. |
动物实验 | In vivo, the I/R model was induced and Apelin 13 was given intracerebroventricularly 15 min before reperfusion.?The neurobehavioral scores, infarction volumes, and some cytokines in the brain were measured. |
分子量 | 1550.83 |
分子式 | C69H111N23O16S |
CAS No. | 217082-58-1 |
store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL (32.24 mM), Sonication is recommended.
DMSO: 50 mg/mL (32.24 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 0.6448 mL | 3.2241 mL | 6.4482 mL | 16.1204 mL |
5 mM | 0.129 mL | 0.6448 mL | 1.2896 mL | 3.2241 mL | |
10 mM | 0.0645 mL | 0.3224 mL | 0.6448 mL | 1.612 mL | |
20 mM | 0.0322 mL | 0.1612 mL | 0.3224 mL | 0.806 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Apelin-13 217082-58-1 inhibit Inhibitor Apelin Receptor (APJ) nervous systems antihypertensive metabolic syndrome Apelin13 diabetes Goto-Kakizaki rat insulin resistance pallidal neurons lipid Apelin 13 Wistar rat vasodilatory inhibitor